跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,614 条关于
“Cloudbreak Therapeutics”
全部
16,614
临床试验
3,570
药物
3,115
机构
1,122
资讯
8,807
9个月前
Cloudbreak Therapeutics Advances CBT-004 to Phase 3 Trials Following Successful FDA Meeting for Vascularized Pinguecula Treatment
3个月前
CLOUDBREAK-B Receives FDA Clearance for CBT-199 Ophthalmic Drug Trial and Submits IND for Dry Eye Candidate CBT-358
去年
Cloudbreak Pharma's CBT-004 Achieves Primary Endpoint in Phase 2 Trial for Vascularized Pinguecula
去年
Cidara's CD388 Shows Promise as Universal Influenza Preventative in Nature Microbiology Publication
去年
Cidara Therapeutics Completes Enrollment in Phase IIb Trial of CD388 for Influenza Prevention
去年
Cidara Completes 5,000-Patient Enrollment in Phase 2b Universal Flu Prevention Trial, Secures $105M Financing
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
3个月前
XRHealth Acquires Swing Therapeutics to Expand Digital Therapeutics Portfolio
去年
Valerio Therapeutics Expands Antibody Development Capabilities with Emglev Therapeutics Acquisition
4年前
Rise Therapeutics Advances Oral Immunotherapies Across Multiple Phase 1 Trials
第 1 页,共 881 页
上一页
下一页